Why the study?
Does local atrial natriuretic peptide infusion alter peripheral blood flow and venous tone in normal subjects?
Does local atrial natriuretic peptide infusion alter peripheral blood flow and venous tone in normal subjects?
Answers are grounded in this paper and cite their sources.
ANP acts locally as an arterioselective dilator in the upper limb circulation in normal humans, with peripheral clearance potentially explaining its short plasma half-life.
The effect on skin and muscle blood flow of arterial infusion of atrial natriuretic peptide (ANP) directly into the forearm circulation, and on venous tone of direct infusion into a dorsal hand vein, was studied in normal subjects. 2. ANP produced a dose-dependent increase in both skin and muscle blood flow, but at equivalent doses, produced no dilatation of noradrenaline-preconstricted dorsal hand veins. These findings indicate that ANP acting locally, is an arterioselective dilator in the upper limb circulation in normal man. 3. Measurements of ANP in venous plasma during arterial infusion suggest marked clearance of ANP across the forearm vascular bed. Such peripheral clearance may, at least in part, account for the short plasma half-life of this peptide. 4. The lowest dose of ANP infused was calculated to produce plasma levels similar to those found in patients with heart failure. The findings with this dose suggest that, in heart failure, circulating levels of ANP may be within a range capable of influencing peripheral vascular resistance directly.
No takes yet. Share an insight, caveat, or question.
Webb et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: